Shuting Xu

994 citations
32 papers · 850 indexed · h-index 14
Topics
Nanoplatforms for cancer theranostics (7 papers)Nanoparticle-Based Drug Delivery (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)

In The Last Decade

Shuting Xu

29 papers receiving 843 citations

Peers

Shuting Xu
Comparison fields: 5 of 102
  • Biomedical Engineering 466
  • Materials Chemistry 328
  • Biomaterials 223
  • Molecular Biology 161
  • Pulmonary and Respiratory Medicine 128
Replace Xinyi Lin with:
Xinyi Lin China
Shuyuan Zhang China
Yuxuan Xiong China
Andrew Dunn United States
Jiajia Wei China
Gang Xu China
Yaojia Zhang China
Ruoxi Yang China
Menglin Wu China
Shuting Xu relative to Xinyi Lin China Xinyi Lin's profile →
Citations per field
00.5×1.5×
Xinyi Lin · 1×
Citations per year

Countries citing papers authored by Shuting Xu

Since Specialization
Citations

This map shows the geographic impact of Shuting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Xu more than expected).

Fields of papers citing papers by Shuting Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Xu. The network helps show where Shuting Xu may publish in the future.

Co-authorship network of co-authors of Shuting Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuting Xu. A scholar is included among the top collaborators of Shuting Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuting Xu. Shuting Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 6
5 2
6 16
7 6
8 58
9 12
10 9
11
Income-Growth Effects of The Rural Industry Integration In Zhejiang Province Of China—An Application of The New GRA Embedded Panel Data Regression Model
4
12 32
13 3
14 263
15 94
16 60
17 58
18 13
19 16
20 3

About Shuting Xu

Shuting Xu is a scholar working on Energy Engineering and Power Technology, Biomaterials and Catalysis, having authored 32 papers that have together received 850 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Biomaterials (223 citations), Biomedical Engineering (466 citations) and Materials Chemistry (328 citations). Shuting Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xinyuan Zhu, Chuan Zhang, Deyue Yan, Yongfeng Zhou, Wei Huang, Yu Huang, Dongbo Guo, Huangyong Jiang, Nan Wang and Wei Huang. Their work appears in journals such as Nature Communications, Biomaterials and The Journal of Physical Chemistry C.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026